ICON specialises in the strategy and delivery of early phase clinical development for informed, timely decision making.
We operate state-of-the-art facilities in the Netherlands and North America, as well as an innovative patient pharmacology model in Central and Eastern Europe. In addition, most of our laboratory facilities are situated close to our clinical facilities and configured to support all study requirements.
Our Early Phase team understands the importance and urgency of early phase patient studies to enable go/no-go decisions quickly.
We incorporate scientific excellence and product develop strategy with expertise in early phase clinical research, bioanalytical, PK/PD modeling & simulation, and the full range of supporting services.
NONMEM is the gold standard software in Population Pharmacokinetic and Pharmacokinetic-Pharmacodynamic modeling. It can be used to fit models to many different types of data.
PDx-Pop software seamlessly integrates with existing tools and its own automated methods to expedite the iterative process of population pharmacokinetic modeling and analysis.
We can serve your early phase testing needs with breakthrough methodologies and proven expertise in high-precision ECG data collection.